313 related articles for article (PubMed ID: 10381799)
1. Peripheral effects of the kappa-opioid agonist EMD 61753 on pain and inflammation in rats and humans.
Machelska H; Pflüger M; Weber W; Piranvisseh-Völk M; Daubert JD; Dehaven R; Stein C
J Pharmacol Exp Ther; 1999 Jul; 290(1):354-61. PubMed ID: 10381799
[TBL] [Abstract][Full Text] [Related]
2. Effect of the peripherally selective kappa-opioid agonist, asimadoline, on adjuvant arthritis.
Binder W; Walker JS
Br J Pharmacol; 1998 Jun; 124(4):647-54. PubMed ID: 9690855
[TBL] [Abstract][Full Text] [Related]
3. Studies with ketamine and alfentanil following Freund's complete adjuvant-induced inflammation in rats.
Edwards SR; Mather LE; Smith MT
Clin Exp Pharmacol Physiol; 2007; 34(5-6):414-20. PubMed ID: 17439409
[TBL] [Abstract][Full Text] [Related]
4. Local peripheral antinociceptive effects of 14-O-methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat.
Obara I; Makuch W; Spetea M; Schütz J; Schmidhammer H; Przewlocki R; Przewlocka B
Eur J Pharmacol; 2007 Mar; 558(1-3):60-7. PubMed ID: 17204264
[TBL] [Abstract][Full Text] [Related]
5. Peripherally mediated antinociception of the mu-opioid receptor agonist 2-[(4,5alpha-epoxy-3-hydroxy-14beta-methoxy-17-methylmorphinan-6beta-yl)amino]acetic acid (HS-731) after subcutaneous and oral administration in rats with carrageenan-induced hindpaw inflammation.
Bileviciute-Ljungar I; Spetea M; Guo Y; Schütz J; Windisch P; Schmidhammer H
J Pharmacol Exp Ther; 2006 Apr; 317(1):220-7. PubMed ID: 16339394
[TBL] [Abstract][Full Text] [Related]
6. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
[TBL] [Abstract][Full Text] [Related]
7. Contribution of opioid receptors on primary afferent versus sympathetic neurons to peripheral opioid analgesia.
Zhou L; Zhang Q; Stein C; Schäfer M
J Pharmacol Exp Ther; 1998 Aug; 286(2):1000-6. PubMed ID: 9694961
[TBL] [Abstract][Full Text] [Related]
8. A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753.
Barber A; Bartoszyk GD; Bender HM; Gottschlich R; Greiner HE; Harting J; Mauler F; Minck KO; Murray RD; Simon M
Br J Pharmacol; 1994 Dec; 113(4):1317-27. PubMed ID: 7889287
[TBL] [Abstract][Full Text] [Related]
9. Loperamide (ADL 2-1294), an opioid antihyperalgesic agent with peripheral selectivity.
DeHaven-Hudkins DL; Burgos LC; Cassel JA; Daubert JD; DeHaven RN; Mansson E; Nagasaka H; Yu G; Yaksh T
J Pharmacol Exp Ther; 1999 Apr; 289(1):494-502. PubMed ID: 10087042
[TBL] [Abstract][Full Text] [Related]
10. Targeted nanoparticles that mimic immune cells in pain control inducing analgesic and anti-inflammatory actions: a potential novel treatment of acute and chronic pain condition.
Hua S; Cabot PJ
Pain Physician; 2013; 16(3):E199-216. PubMed ID: 23703419
[TBL] [Abstract][Full Text] [Related]
11. Antinociceptive actions of dexmedetomidine and the kappa-opioid agonist U-50,488H against noxious thermal, mechanical and inflammatory stimuli.
Idänpään-Heikkilä JJ; Kalso EA; Seppälä T
J Pharmacol Exp Ther; 1994 Dec; 271(3):1306-13. PubMed ID: 7996439
[TBL] [Abstract][Full Text] [Related]
12. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats.
Wang JY; Zhao M; Yuan YK; Fan GX; Jia H; Tang JS
Neuroscience; 2006; 138(4):1319-27. PubMed ID: 16472929
[TBL] [Abstract][Full Text] [Related]
13. The role of gonadal hormones on opioid receptor protein density in arthritic rats.
Kren MC; Haller VL; Welch SP
Eur J Pharmacol; 2008 Jan; 578(2-3):177-84. PubMed ID: 18054782
[TBL] [Abstract][Full Text] [Related]
14. The peripheral antinociceptive effects of endomorphin-1 and kynurenic acid in the rat inflamed joint model.
Mecs L; Tuboly G; Nagy E; Benedek G; Horvath G
Anesth Analg; 2009 Oct; 109(4):1297-304. PubMed ID: 19762760
[TBL] [Abstract][Full Text] [Related]
15. The peripherally acting kappa-opiate agonist EMD 61753 and analogues: opioid activity versus peripheral selectivity.
Gottschlich R; Barber A; Bartoszyk GD; Seyfried CA
Drugs Exp Clin Res; 1995; 21(5):171-4. PubMed ID: 8846746
[TBL] [Abstract][Full Text] [Related]
16. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.
Sluka KA; Rohlwing JJ; Bussey RA; Eikenberry SA; Wilken JM
J Pharmacol Exp Ther; 2002 Sep; 302(3):1146-50. PubMed ID: 12183674
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous, intrathecal and periaqueductal grey administration of asimadoline and ICI-204448 reduces tactile allodynia in the rat.
Caram-Salas NL; Reyes-García G; Bartoszyk GD; Araiza-Saldaña CI; Ambriz-Tututi M; Rocha-González HI; Arreola-Espino R; Cruz SL; Granados-Soto V
Eur J Pharmacol; 2007 Nov; 573(1-3):75-83. PubMed ID: 17643411
[TBL] [Abstract][Full Text] [Related]
18. Contralateral but not systemic administration of the kappa-opioid agonist U-50,488H induces anti-nociception in acute hindpaw inflammation in rats.
Bileviciute-Ljungar I; Spetea M
Br J Pharmacol; 2001 Jan; 132(1):252-8. PubMed ID: 11156584
[TBL] [Abstract][Full Text] [Related]
19. Central and peripheral actions of the novel kappa-opioid receptor agonist, EMD 60400.
Barber A; Bartoszyk GD; Greiner HE; Mauler F; Murray RD; Seyfried CA; Simon M; Gottschlich R; Harting J; Lues I
Br J Pharmacol; 1994 Mar; 111(3):843-51. PubMed ID: 8019761
[TBL] [Abstract][Full Text] [Related]
20. Effect of a kappa-opioid agonist, i.v. JNJ-38488502, on sensation of colonic distensions in healthy male volunteers.
Floyd BN; Camilleri M; Busciglio I; Sweetser S; Burton D; Wong GY; Kell S; Khanna S; Hwang S; Zinsmeister AR
Neurogastroenterol Motil; 2009 Mar; 21(3):281-90. PubMed ID: 18823290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
